Linda Eckert, Professor, Dept of ObGyn and Dept of Global Health at University of Washington, shared a post on LinkedIn:
“Two new wonderful robust Cochrane reviews out today showing the impact of HPV vaccination to decrease cervical cancer, cervical precancer and genital warts – including a population level analysis demonstrating just how remarkable safe this HPV vaccine is when evaluating 225 studies from 347 records, evaluating over 132 million people!”
Julie S. Torode, Director of Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy at King’s College London, shared Linda Eckert‘s post, adding:
“Even more data to support rollout of the safe and efficacious HPV vaccination programs in all high burden countries as one part of the three pronged approach to elimination of cervical cancer.
N=17 countries in Africa have NO HPV vaccination, but those that have are showing high coverage rates. World Health Organization Gavi, the Vaccine Alliance can do more to help affordability as more HPV vaccines are coming into the market place.”
Read more posts featuring Linda Eckert on OncoDaily.